“A RANDOMISED, BLINDED, PLACEBO-CONTROLLED, THREE ARMED PARALLEL STUDY ON ELECTROPHOTONIC IMAGE CHANGES DURING HOMOEOPATHIC PATHOGENETIC TRIAL USING MOLECULAR AND ULTRA-MOLECULAR DOSES - A REPROVING OF BELLADONNA”
收藏资源简介：
“A RANDOMISED, BLINDED, PLACEBO-CONTROLLED, THREE ARMED PARALLEL STUDY ON ELECTROPHOTONIC IMAGE CHANGES DURING HOMOEOPATHIC PATHOGENETIC TRIAL USING MOLECULAR AND ULTRA-MOLECULAR DOSES - A REPROVING OF BELLADONNA” ABSTRACT: Background: Homoeopathic drug proving is the process of understanding the pathogenetic powers of the dynamised Homoeopathic drugs on healthy human beings. In homoeopathic drug proving due to the biomimicry of production of disease symptoms, there are tremendous chances for the altered electron communication which may produce changes in the Electro-photonic Emission. Although controversies exist on the action of Belladonna in the healthy human provers (Good year et al (1998), H. Wallah et al (2001), S Brien et al(2003)). This study takes up the challenge to re-evaluate the efficacy of Belladonna in homoeopathic pathogenetic trial in the molecular and ultra-molecular doses. Method: Randomised, blinded, placebo-controlled three-armed (Belladonna6C, Belladonna200C and Placebo) parallel study (n = 150) conducted in National Institute of Homoeopathy, India. The study design was framed as a four-week protocol consisting of Pre-Intervention period, Intervention Period, Post Intervention period for each participant. Primary and Secondary Outcome Measures are Twelve parameters of Electro Photonic Imaging [EPI] technique and Q-Form-02 (30 items, Likert scale questionnaire) respectively. Result: The analysis showed a statistically significant difference in eight parameters (P-value <0.05,) out of twelve parameters and the Form Coefficient parameter (P-value <0.001) revealed the effect of placebo during the run-in phase. The questionnaire Q-Form-02 analysis revealed a significant difference among the three groups. The post hoc analysis showed the number of symptoms and the scores among groups depicted the trend: Belladonna 6C > Belladonna 200C > Placebo. Conclusion: We may conclude that the Electro Photonic Emissions from the human body may serve as a parameter to differentiate the placebo effect from the Homoeopathic medicine effect in the Homoeopathic Pathogenetic Trial [Trial Registration: CTRI/ 2018/03/012290].
一项针对顺势疗法病原学试验中使用分子与超分子剂量时电子光子图像变化的随机、双盲、安慰剂对照三臂平行研究——重评颠茄（Belladonna） 摘要：背景：顺势疗法制剂病原学试验（Homoeopathic Pathogenetic Trial）是指通过健康人体探究经动力化处理的顺势疗法制剂致病效力的过程。在顺势疗法制剂病原学试验中，由于其疾病症状生成机制具有生物拟态特性，极有可能引发电子通信通路改变，进而导致电子光子发射（Electro-photonic Emission）出现变化。尽管目前针对颠茄在健康受试者试验中的作用仍存在争议（Goodyear等人，1998年；H. Wallah等人，2001年；S. O'Brien等人，2003年），本研究旨在对分子与超分子剂量下颠茄在顺势疗法病原学试验中的效力进行重新评估。 方法：本研究于印度国家顺势疗法研究院开展，为一项随机、双盲、安慰剂对照三臂（颠茄6C、颠茄200C与安慰剂）平行试验，共纳入150名受试者（n=150）。研究方案为期四周，涵盖所有受试者的干预前阶段、干预阶段与干预后阶段。主要结局指标为电子光子成像（Electro Photonic Imaging, EPI）技术的12项参数，次要结局指标为Q-Form-02问卷（共30项条目，采用李克特量表评分）。 结果：分析结果显示，12项参数中有8项存在统计学显著性差异（P值<0.05）；其中形态系数参数（P值<0.001）揭示了导入期内安慰剂的效应。Q-Form-02问卷分析结果显示，三组受试者间存在显著差异。事后分析显示，各组的症状数量与评分呈现如下趋势：颠茄6C组 > 颠茄200C组 > 安慰剂组。 结论：本研究可得出如下结论：人体产生的电子光子发射可作为区分顺势疗法病原学试验中安慰剂效应与顺势疗法制剂效应的一项指标。[试验注册号：CTRI/2018/03/012290]
